Imaging on Core Muscles Function in Patients With Visceral Adiposity

Obesity, Abdominal Clinical Trial

Official title:

Impact of Rehabilitative Ultrasonography Imaging on Core Muscles Function in Patients With Visceral Adiposity: Randomized Controlled Trail

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05690659
• Other study ID #: P.T.REC/012/003449
• Status: Completed
• Phase: N/A
• Start date: August 1, 2022
• Est. completion date: January 20, 2023

Study information

• Verified date: September 2023
• Source: Deraya University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of cavitation ultrasonic lipolysis, RUSI guided core muscle exercise and their combination (cavitation ultrasonic lipolysis and RUSI guided core muscles exercise) on diaphragmatic excursion, transverse abdominis activation ratio, visceral fat thickness and waist circumference in patients with visceral adiposity patients with visceral adiposity will be recognized by nutrition specialist. 45 patients were distributed randomly into three groups. The first group will be treated with Cavitation lipolysis twice weekly. The second group was treated with rehabilitative ultrasound imaging (RUSI) guided core muscle exercise. The third group was treated with combination of cavitation and RUSI. patients will be examined with medical ultrasound imaging and tape measurement.

Description:

• Inclusion criteria: Forty five subjects participated in this study. Age of participants ranged from 25 to 45 years. 3. Waist circumference was more than 102 cm for men and 88 cm for women 4. Body mass index (BMI) ranged from 25 to 29.9 (Kg / m2). 5. Subjects hadn't received drugs

Exclusion criteria:

1. history of spinal surgery or spinal fracture.

2. Serious diseases, such as heart disease, kidney, liver diseases, gastric ulcer or duodenal ulcer.

3. A history of bronchial asthma or any chest disease.

4. Uncontrolled diabetes or hypertension.

5. Patients with peacemaker or any metal implant on the treated area.

6. Cancer or patient with past history of tumor excision

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: January 20, 2023
• Est. primary completion date: November 20, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 25 Years to 45 Years

Eligibility

Inclusion Criteria:

• Forty five subjects participated in this study.

• Age of participants ranged from 25 to 45 years.

• Waist circumference was more than 102 cm for men and 88 cm for women

• Body mass index (BMI) ranged from 25 to 29.9 (Kg / m2).

• Subjects hadn't received drugs

Exclusion Criteria:

.history of spinal surgery or spinal fracture.

• Serious diseases, such as heart disease, kidney, liver diseases, gastric ulcer or duodenal ulcer.

• A history of bronchial asthma or any chest disease.

• Uncontrolled diabetes or hypertension.

• Patients with peacemaker or any metal implant on the treated area.

• Cancer or patient with past history of tumor excision.

Related Conditions & MeSH terms

• Obesity, Abdominal

Intervention

Other:
• device and exercise
cavitation ultrasonic device therapeutic exercise guided ultrasonography imaging

Locations

Country	Name	City	State
Egypt	Deraya university	Minya

Sponsors (1)

Lead Sponsor	Collaborator
Deraya University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	diaphragm excursion	by ultrasound imaging in centimeter	five weeks
Primary	transverse abdominins contraction ratio	by ultrasound imaging in percent	5 weeks
Secondary	visceral fat thickness	by ultrasound imaging in centimeter	5 weeks
Secondary	waist circumference	by tape measurement	5 weeks